Venus Medtech (Hangzhou) Inc. (SEHK: 2500)
Health Care · Health Care Equipment & Supplies · CN
HK$1.10
-8.37% today · -63.7% 1Y
Venus Medtech (Hangzhou) Inc. (SEHK: 2500) operates in the Health Care Equipment & Supplies industry within the Health Care sector. The company is valued at $61.10M and employs 557 people.
Over the last twelve months the share price has lost 63.7%, trading between 0.94 and 3.86.
Tweenvest scores Venus Medtech (Hangzhou) Inc. across four factors: quality 37/100, value 45/100, growth 0/100. Its strongest factor is value.
2500 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $61.10M
- Revenue (TTM)
- $37.56M
- P/E
- —
- EPS
- -1.06
- Dividend yield
- —
- Beta (5Y)
- 1.11
- 52-week high
- HK$3.86
- 52-week low
- HK$0.94
- Avg volume (3M)
- —
- Shares outstanding
- 437.90M
- Employees
- 557
- Next earnings
- —
About Venus Medtech (Hangzhou) Inc.
Venus Medtech (Hangzhou) Inc., together with its subsidiaries, engages in the research, development, manufacturing, and sale of bioprosthetic heart valves in Mainland China and internationally. The company’s offers transcatheter aortic heart valve replacement products, such as VenusA-Valve, VenusA-Plus, VenusA-Pro, and VenusA-Deluxe; and VenusP-Valve, a transcatheter pulmonary valve system to treat the patients suffering with moderate to severe pulmonary regurgitation with or without right ventricular outflow tract stenosis. It also develops Venus-Vitae, a balloon-expandable dry-tissue product; Venus-PowerX, a self-expanding dry-tissue product; Cardiovalve, a transcatheter valve replacement system for the treatment of patients with mitral regurgitation and in pivotal clinical trial for the treatment of patients with tricuspid regurgitation; Liwen RF, a radiofrequency ablation system for the treatment of hypertrophic cardiomyopathy; and renal artery denervation ablation system for the treatment of hypertension. In addition, the company offers procedural accessories comprising catheter sheath product and balloon catheter. Venus Medtech (Hangzhou) Inc. was incorporated in 2009 and is headquartered in Hangzhou, the People’s Republic of China.
- ISIN
- CNE100003PJ8
- Founded
- 2009
- Listed since
- Dec 10, 2019
- Exchange
- The Stock Exchange of Hong Kong Ltd.
- Currency
- HKD
Other Health Care Equipment & Supplies companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Creo Medical Group PLCAIM: CREO | $62.28M | £0.11 | +8.81% |
| Abingdon Health PlcAIM: ABDX | $61.89M | £0.11 | -2.27% |
| Austco Healthcare LimitedASX: AHC | $61.46M | AU$0.24 | -6.00% |
| OK Biotech Co., Ltd.TWSE: 4155 | $61.26M | NT$14.20 | -4.38% |
| Daxor CorporationNasdaqCM: DXR | $60.78M | $10.41 | -1.98% |
| Vincent Medical Holdings LimitedSEHK: 1612 | $60.56M | HK$0.72 | +6.67% |
| Corentec Co., Ltd.KOSDAQ: A104540 | $59.14M | ₩5,930.00 | +15.15% |
| Medinotec Inc.OTCPK: MDNC | $58.67M | $— | — |
Figures last refreshed Oct 11, 2026.